|
Friday 15th September 2023 |
Text too small? |
Auckland, New Zealand, 15 September 2023 - Fisher & Paykel Healthcare Corporation Limited attaches a copy of its presentation to analysts and investors for its Investor Event held over the next two days in Tijuana, Mexico and Irvine, California.
There is no new material information contained within the presentation.
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in over 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.
No comments yet
THL - FY26 Interim Results: underlying NPAT up 11%, 3cps dividend
FPH updates FY26 revenue and earnings guidance
February 23rd Morning Report
February 20th Morning Report
SCL - Chief Financial Officer Transition
BLS - Strong YTD performance
CEN announces opening of NZ$75 million Retail Offer
AIA - 1H26 Interim Results
February 19th Morning Report
TWL - Share Purchase Plan Results